English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Refractory to apoptosis induced by anticancer drugs is one of the major causes of drug resistance in human cancers. The involvement of noncoding RNA (ncRNA) in cancer cell drug resistance has not yet been reported. By using the technique of RT-PCR-based differential display, a novel gene,  cancer up-regulated drug resistant (CUDR)  gene, was found to be overexpressed in a doxorubicin-resistant subline of human squamous carcinoma A431 and A10A cells, which were also more resistant to drug-induced apoptosis. The full-length  CUDR  mRNA transcript is ∼2.2 kb as detected by Northern blot analysis and has no sequence homology with other genes identified so far. Interestingly, no distinct open reading frame was found throughout the  CUDR  cDNA sequence, and no recombinant protein was detected from in vitro translation or from a protein lysate of human cancer cells after  CUDR  transfection. Therefore,  CUDR  is likely to exert its function as a noncoding RNA. Stable transfection with the  CUDR  gene was found to induce resistance to doxorubicin and etoposide as well as drug-induced apoptosis in A431 cells. By Western blot analysis, down-regulations of caspase 3 were observed in  CUDR  transfectants. On the other hand, overexpression of  CUDR  promoted anchorage-independent growth in A431 cells. Results from the present study suggest that  CUDR  may likely regulate the drug sensitivity and promote cellular transformation at least through caspase 3-dependent apoptosis.

Induction of drug resistance and transformation in human cancer cells by the noncoding RNA CUDR